Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /ORCHPHARMA
chevron_leftBack

Orchid Pharma Ltd.

ORCHPHARMA
NSE: ORCHPHARMA Delayed
811.20INR 0.1%
9.49 USD
As of 24 April 2025, Orchid Pharma Ltd. has a market cap of $481.84M USD, ranking #12130 globally and #794 in India. It ranks #1186 in the Healthcare sector, and #286 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
12130
Country Rank
794
Sector Rank
1186
Industry Rank
286
Key Stats
Market Cap
$481.84MUSD
41.12B INR
Enterprise Value
$471.65MUSD
40.33B INR
Revenue (TTM)
$105.65MUSD
9.02B INR
EBITDA (TTM)
$11.65MUSD
996.32M INR
Net Income (TTM)
$13.0MUSD
1.11B INR
EBITDA Margin
11%
Profit Margin
12%
PE Ratio
37.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Manish Dhanuka open_in_new
Employees
871
Founded
1992
Website
orchidpharma.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.1% 4.5% -1.7% -48% -35% -23%
Upcoming Earnings
Earnings Date
Fri, May 30

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
ORCHPHARMA
Orchid Pharma Ltd
ISIN: INE191A01027
Shares Out.:
50.719M1 Shares Float: 13.367M2
TV:
SA:
YF:
GF:
BA:
MS:
811.20 INR
Bombay Stock Exchange
MIC: XBOM
524372 (ORCHPHARMA)
Orchid Pharma Ltd
ISIN: INE191A01027
TV:
SA:
YF:
GF:
BA:
MS:
719.40 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Orchid Pharma Ltd.

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company has multi-therapeutic presence in anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 countries internationally. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is based in Narsinghpur, India. Orchid Pharma Limited operates as a subsidiary of Dhanuka Laboratories Limited.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)
Name
Market Cap diff.
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.13B
4.19T INR
10K%
Divi's Laboratories Ltd.
DIVISLAB
$18.39B
1.57T INR
4K%
Cipla Ltd.
CIPLA
$14.46B
1.23T INR
3K%
Torrent Pharmaceuticals Ltd.
TORNTPHARM
$13.23B
1.13T INR
3K%
Mankind Pharma Ltd.
MANKIND
$12.47B
1.06T INR
2K%
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
14K%
Merck KGaA
MRK
$59.42B
52.43B EUR
12K%
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
10K%
Haleon plc
HLN
$45.57B
34.34B GBP
9K%
Galderma Group AG
GALD
$23.06B
19.13B CHF
5K%